CF
ANRO icon

Corebridge Financial’s Alto Neuroscience ANRO Stock Holding History

Corebridge Financial’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,465
Closed -$22.6K – 2889
2025
Q1 		$22.6K Sell
10,465
-155
-1% -$555 ﹤0.01% 2889
2024
Q4 		$44.9K Sell
10,620
-802
-7% -$5K ﹤0.01% 2855
2024
Q3 		$131K Buy
11,422
+6,651
+139% +$81.4K ﹤0.01% 2465
2024
Q2 		$51K Buy
+4,771
New +$62.1K ﹤0.01% 2889

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Corebridge Financial's ANRO Position: Q2 2025 in Review

Corebridge Financial sold out of Alto Neuroscience (ANRO) in Q2 2025, closing a stake of 10,465 shares — an estimated $22.6K sold.

Corebridge Financial first reported a position in ANRO in Q2 2024 and held it in 4 quarters. The position peaked at $131K in Q3 2024. 80 funds tracked by Wall St. Rank hold ANRO as of Q2 2025.

  • Corebridge Financial reported no remaining Alto Neuroscience position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 10,465 Alto Neuroscience shares in Q2 2025, an estimated $22.6K.
  • Corebridge Financial first reported a position in Alto Neuroscience in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Alto Neuroscience position peaked at $131K in Q3 2024.
  • 80 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.